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ABSTRACT

Author: Sukumar, Kevinraj, N. MS
Institution: Purdue University
Degree Received: August 2018
Title: Detection of Arsenic in Skin In Vivo Using Portable X-Ray Fluorescence (PXRF) Device
Major Professor: Dr. Linda H Nie
Arsenic is an element that is highly toxic in its inorganic form. It is widely distributed especially
in water that becomes a primary source of exposure for human consumption. Chronic exposure
can cause a variety of diseases such as lung cancer, bladder cancer, skin cancer, vascular
diseases, and diabetes mellitus. Biomarkers for arsenic exposure are tissues that contain keratin
such as hair, nails, and skin. Skin is an ideal biomarker due to its cumulative property that
provides information about the individual long-term exposure to arsenic. Hence, a method for
measuring arsenic levels in vivo will be useful to study the harmful effects of arsenic exposure.
In this research, a portable x-ray fluorescence (XRF) device was used to determine its feasibility
of detecting and quantifying arsenic in human skin. Arsenic-doped skin phantoms were used to
calibrate the system. These phantoms were made using a mixture of fiberglass resin, salt
solution, arsenic standard solution, and liquid hardener.

In order to simulate in vivo

measurement setting, lucite was used as a backing material that mimics the underlying soft
tissue. The device was set at its maximum tube voltage of 50kV, 40µA, and silver filter. Each
fluorescence data was measured for 180 seconds. The instrumental minimum detection limit
(MDL) obtained using the phantoms alone is 0.17ppm. Meanwhile, the MDL obtained for a
setup involving phantoms and lucite thickness of 4.44mm and 9.78mm are 0.21ppm and
0.23ppm respectively.
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CHAPTER 1: INTRODUCTION

1.1 Arsenic
Arsenic is a ubiquitous element. The Earth’s crust contains widely distributed arsenic among
other abundantly available elements. Arsenic is a metalloid although it is generally referred to as
metal; it displays both metal and non-metal characteristics ("Arsenic Public Health Statement,"
2007). It is almost indistinguishable due to its inherent characteristics: colorless, odorless, and
tasteless. Thus, it is difficult to detect the presence of arsenic without appropriate tests. Arsenic
binds with oxygen, sulfur, and chlorine to form inorganic compounds. Meanwhile, arsenic also
binds with carbon and hydrogen in its organic compounds.

1.1.1 Sources of Arsenic
Arsenic (As) is a naturally occurring element which is commonly associated with minerals and
ores rather than found independently. Inorganic arsenic compounds can be found with ores with
copper and lead ("Arsenic Public Health Statement," 2007). Pyrite and pyrrhotite are both iron
sulfide minerals with higher arsenic concentration in the former than latter (O'Shea et al., 2015).
Additionally, metal oxides display strong association with arsenic. In sediment layers and host
rocks, arsenic is found with minerals such as arsenopyrite, scorodite, and iron hydroxide (Basu &
Schreiber, 2013). However, arsenic is not always immobile and bound to rocks. Weathering of
these minerals and ores releases arsenic into groundwater which transports this toxicity to
widespread locations and ultimately human exposure. The weathering of arsenopyrite initiates
oxidation to produce scorodite which undergoes incongruent dissolution to form iron hydroxides,
releasing close to 96.2% of its solid arsenic into water (Basu & Schreiber, 2013). Groundwater is
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not the only water medium to carry toxic arsenic levels but arsenic can contaminate surface
water, drinking water, wastewater, and snow. In Poland, 97% of total arsenic concentration in
snow was arsenite [As(III)], extremely toxic arsenic form, due to polluted urban air where
airborne arsenic particles are most prominent (Komorowicz & BaraAkiewicz, 2016). Meanwhile,
high level of arsenic is present in soils. Arsenic distribution is highly correlated with iron and
sulfur abundance in soil samples (Kim, Yoo, & Baek, 2014). Hence, soils which are rich with
iron and sulfur suggest the presence of high level of arsenic. In addition to natural release from
arsenic-bearing minerals, arsenic is also removed from its binding by mining and smelting which
further contaminate soils (Kim et al., 2014).

Besides natural processes that release arsenic from its bound state, anthropogenic activities
further induce environmental toxicity. Smelting of ores containing copper and lead liberate
arsenic trioxide [As2O3] as dust particles ("Arsenic Public Health Statement," 2007). These
inorganic arsenic compound as airborne particles can get into human system via inhalation. Also,
arsenic is introduced to plantations and farms via agricultural products. Rodenticides, herbicides,
insecticides include arsenite due to its high solubility and immediate fatal impact (Vladimir &
Florence Yan Li, 2017). Not only has agricultural arsenic product been used to control pests to
promote crop growth, but it has been historically used as a tool of war strategy. Agent Blue
(dimethylarsinic acid) was used as herbicides by the US troop during Vietnam War to destroy
crops and reduce food supply for their enemies (Vladimir & Florence Yan Li, 2017).
Agricultural uses of arsenic products contaminate food sources which endanger human health
status. Not only regular dietary foods, but these agricultural materials and geological features can
lead to accumulation of arsenic in tobacco products. Tobacco leaves absorb arsenic from farming
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factors such as soils, pesticide, and fertilizer (Lazarević et al., 2012). This suggests that any
products based on these arsenic contaminated tobacco leaves will contain residual levels of
arsenic as it enters human systems.

Additionally, arsenic can be found in wood preservative, automobiles, light emitting diodes,
semiconductors, volcanos, and incinerators ("Arsenic Public Health Statement," 2007). This
indicates the widespread presence of arsenic, organic or inorganic, in our immediate
surroundings.

1.1.2 Exposure Pathways and Metabolism in Humans
Humans can get exposed to arsenic via ingestion and inhalation. Ingestion can take place through
drinking water and dietary food; there is conflicting agreement on the primary arsenic exposure
between these two routes. In Vietnam, residents along the Red River Delta consume sand filtered
groundwater which can result in accumulation of 1µg/g As in hair if the filtered water contains
approximately 96µg/L As (Agusa et al., 2014). On the other hand, some studies suggest that food
delivers higher concentration of inorganic arsenic (iAs). Based on one study, the major food
sources for iAs exposure were vegetables, fruits (including extracted juices), rice, alcohol (beer
and wine), and grain products (corn, wheat, and flour) (Xue, Zartarian, Wang, Liu, &
Georgopoulos, 2010). Meanwhile, humans can get exposed to arsenic via breathing. As
mentioned earlier, smelters and general population can be exposed to arsenic trioxide which
becomes dust particles ("Arsenic Public Health Statement," 2007).
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Arsenic undergoes biomethylation in the human system. Among the organs, the liver is primarily
involved in methylation of iAs (Styblo et al., 1999). The iAs is converted into mono- and dimethylated species (Agusa et al., 2014; Styblo et al., 1999). Once inside the human body, iAs
rapidly reaches the liver as hepatocytes express iAs content an hour after exposure and
subsequently declines; mono- and di-methylated arsenic metabolites are observed within a day of
exposure (Styblo et al., 1999). Arsenic is then removed out of the body via urine. Majority of the
arsenic in urine is dimethyl arsenic with lesser amounts of iAs and monomethyl arsenic
(Loffredo, Aposhian, Cebrian, Yamauchi, & Silbergeld, 2003).

1.1.3 Arsenic Induced Diseases
Arsenic has also been determined to be a pulmonary carcinogen. Both ingestion and inhalation of
arsenic have almost similar risk potential for lung cancer development although with uncertain
mechanisms (Allan, Ayse, Yan, & Craig, 2009). Inhalation provides a direct access to lungs. So,
it is fair to assume that inhalation will be more carcinogenic rather than ingestion which does not
introduce arsenic to the pulmonary region directly. Consumption of drinking water contaminated
with increasing levels of arsenic has been shown to result in greater prevalence of lung cancer
(Ferreccio et al., 2000). The iAs is special in terms of being carcinogenic to lungs via both
ingestion and inhalation rather than only one of the routes (Allan et al., 2009). Lung cancer due
to arsenic exposure can be exacerbated by additional risk factors. In Northern Chile, smokers had
an odds ratio of 32.0 for developing lung cancer especially when combined with consumption of
drinking water with an average arsenic concentration of 200µg/L (Ferreccio et al., 2000).
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Besides lung cancer, ingestion of arsenic is a serious risk factor for bladder cancer among
consumers. The absence rather than presence of this carcinogen is a good indicator of etiology
for bladder cancer. Residents of the black foot disease endemic area (BFDEA) in southwest of
Taiwan were exposed to extreme levels of arsenic in their drinking water but displayed reduced
cancer incidence after clean water system was installed. In general, incidence of lung and bladder
cancer dropped dramatically after highly exposed residents, especially younger generation, were
supplied with clean water (Su, Lu, Tsai, & Lian, 2011). The relative risk for bladder cancer was
lower for residents born post-1943, age around 30 years during installation of clean water supply,
than elder residents (Su et al., 2011). High level or arsenic contamination has been proven to be
associated with bladder cancer as shown by the Taiwanese population. On the other hand, low
levels of arsenic have the possibilities of inducing bladder cancer risks but its etiology is not
firmly established as high levels of arsenic contamination. In a study conducted in New
Hampshire, majority of case subjects were active smokers with toenail arsenic accumulations
range of 0.014-2.484µg/g (Karagas et al., 2004). Individuals who weren't smokers displayed
almost no association between their toenail arsenic accumulation and risks of bladder cancer
(Karagas et al., 2004). Hence, arsenic exposure in small amounts alone is not sufficient to
present significant bladder cancer risks. In contrast to non-smokers, the risk of contracting
bladder cancer was highest among smokers with greatest arsenic exposure (Karagas et al., 2004).
This suggests that additional cofactor such as smoking is necessary to enhance the effect of low
arsenic levels on bladder cancer.

In addition to the cancers mentioned above, arsenic has been well established as a risk factor for
vascular diseases. A unique peripheral vascular disease, locally known as blackfoot disease, was
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common in a specific region along the southwest coast of Taiwan (Tseng, 2002, 2005; Tseng et
al., 2005). One of the visible symptoms is dark blemish forming at feet of affected individuals
(Tseng, 2002) which is attributed as the origin of the local disease name. Residents with this
disease display gangrene at extremities, feel numb or cold near the end of their limbs, experience
cramping pain due to reduced blood flow before the onset of gangrene, and peripheral arterial
pulse waves (Tseng, 2002, 2005; Tseng et al., 2005). Another indication of blackfoot disease is
ulcer formation (Tseng, 2002). Most of the patients succumbed to amputation of their lower
limbs (Tseng, 2002; Tseng et al., 2005). Not every exposed residents developed peripheral
vascular disease. It could be due to individual variable factors such as genetics and environment;
individuals capable of efficient secondary arsenic methylation have reduced risk of developing
peripheral vascular disease (Tseng et al., 2005). Residents with either well water or tap water as
their drinking source displayed different incidence rates; occurrence of blackfoot disease also
decreased after clean water via tap system was installed (Tseng, 2002, 2005). This indicates that
a link exist between arsenic exposure and development of blackfoot disease.

Diabetes mellitus is one of the determinants for peripheral vascular disease and coronary heart
disease (Lai et al., 1994; Rahman, Tondel, Ahmad, & Axelson, 1998). There is strong correlation
between arsenic exposure and development of diabetes mellitus. Prevalence of diabetes was
highly correlated with total arsenic exposure; the greater the arsenic accumulation, the greater the
diabetic prevalence (Lai et al., 1994). However, there are other factors that affect diabetes
prevalence among exposed individuals such as age, gender, and lifestyle. In the arsenic
hyperendemic region of Taiwan, both genders displayed higher prevalence of diabetes mellitus at
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older age (Lai et al., 1994). Meanwhile, active subjects had lower prevalence of diabetes than
those who were inactive (Lai et al., 1994).

1.1.4 Skin Diseases
Several studies have reported strong association between arsenic exposure and skin diseases, the
visible signs of health degradation among victims. Arsenic speciation based on urine samples
from subjects with skin cancer have identified greater levels of total arsenic and monomethyl
arsenic but smaller level of dimethyl arsenic than they are among healthy individuals (Hsueh et
al., 1997). Arsenic exposure does not cause all types of skin cancers. Among the skin lesions,
squamous cell carcinoma and basal cell carcinoma are common among exposed population while
malignant melanoma shows almost no association with arsenic poisoning (Guo, Yu, Hu, &
Monson, 2001).

1.1.5 Biomarkers of Arsenic Exposure
The manifestation of arsenic exposure can be qualitatively determined based on observation of
signs and symptoms. Abnormal visual appearances on the skin layer are an easy and immediate
method to determine exposure to arsenic. Skin disorder such as keratosis is an alternative
biomarker to assess subjects in identifying arsenical exposure when absolute evaluation of
arsenic source is not available (Rahman et al., 1998).

Biomarkers with potential for quantitative analysis are a better option instead of relying on signs
and symptoms which are subject to individual interpretation. Arsenic targets regions in human
body with abundance of keratin where it binds with the sulfhydryl component in keratin (Agusa
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et al., 2014). Some human tissues with keratin are nail, hair, and skin. These tissue samples
provide good record on long term arsenic exposure. For example, hair is a good indicator of
cumulative arsenic exposure (Agusa et al., 2014). However, hair is not an ideal biomarker for
assessment using XRF analysis due to its small surface area. Nails are usually extracted from
individuals and can present logistic errors. Also, it is subjected to destructive sample preparation
for analysis using methods like inductively coupled plasma mass spectrometry (McIver et al.,
2015). On the other hand, skin is an ideal biomarker for XRF analysis due to larger surface area.
In addition to that, a particular location on the human body can be marked and repeated
measurements can be performed to study long term arsenic exposure. Most importantly, arsenic
exposure can manifest into skin diseases such as cancer and therefore skin is the most relevant
biomarker for this study.

Besides these tissues, another common biological sample that is used to assess arsenic level in
human body is urine. Urinary samples are collected to assess individual arsenic metabolic
capacity (Tseng et al., 2005). While hair is used to evaluate chronic exposure, urine is good for
acute exposure (Agusa et al., 2014). Also, urine is a better option to distinguish the various
arsenic species as processed by the human system (Agusa et al., 2014). Some arsenic species that
can be detected are dimethylarsinic acid, monomethylarsonic acid, arsenobetaine (Xue et al.,
2010), inorganic arsenite, and inorganic arsenate (Tseng et al., 2005). Organic arsenic such as
arsenobetaine, found in seafood, is not harmful and is usually removed in its original form
(Tseng et al., 2005). On the other hand, inorganic arsenic is the element of interest due to its
toxicity.
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1.2 X-Ray Fluorescence (XRF)
1.2.1 Principles of XRF
X-ray fluorescence (XRF) is a physical phenomenon where a high energy x-ray or gamma ray is
used to remove an orbital electron in a material which will then release a secondary or
fluorescent x-ray specific to an element. This physical phenomenon is commonly applied to
elemental analysis. The primary physical interaction involved here is photoelectric effect. An xray or gamma ray with sufficient energy is used to bombard an electron in the inner orbits of an
atom. The incident photon must have energy greater than the binding energy of an electron in
order to eject it from its respective shell. The released electron is referred to as photoelectron
which is a result of the aforementioned photoelectric effect. The residual energy from the
incident photon after overcoming binding energy is transferred into kinetic energy for the
photoelectron to travel beyond the atom. Now, another electron from a higher orbit will drop
down to fill up the vacant spot left by the photoelectron. This transfer of electron releases energy
in order to conserve energy, equivalent to the difference between the binding energies of initial
and final positions of the migrating electron, in the form of a photon. The emitted photon known
as fluorescence x-ray with characteristic energy is unique to the element present in the sample.
Another possible emission due to conservation of energy is the Auger electron. If the excess
energy is not released via fluorescence x-ray, then this surplus energy will be used to knock out
an electron from higher orbital shells. Atoms have multiple orbital shells identified as K, L, M, N
and so on. Each element has a specific energy configuration or order between its shells. The
characteristic energy and fluorescence x-ray intensity can be used to determine the amount of
available element in the sample.
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1.2.2 Portable XRF
Portable or handheld XRF device is used in a wide range of fields and applications that require
elemental analysis. This includes geological sampling in mining activities and elemental
identification in recycled metals. The portable XRF device used in this research is the Niton
XL3t GOLDD+ XRF Analyzer by Thermo Fisher. It features a silver (Ag) anode tube with
voltage and current ranges of 6-50kV and 0-200µA respectively. Also, various combination of
filter material is available. This device collects information about the fluorescence using a silicon
drift detector (SDD). Instead of standard SDD, the geometrically optimized large area drift
detector (GOLDD) has greater surface area for better detection. This thermoelectrically cooled
detector has 25mm2 of surface area and 1mm of thickness.

The XRF device is powered by lithium-ion battery which is rechargeable. Also, a charge-coupled
device camera is in place to locate and position the sample in the beam’s eye-view. Its settings
can be adjusted via the tiltable touch screen display which also produces results of test with
peaks and list of elements. For the purpose of this research, the data was transferred to a
computer via USB and accompanying software. A test stand is provided with the device to hold
the analyzer in place for the test duration in lab. The test stand provides shielding from external
sources of radiation and prevents any radiation leakage. There are safety interlocks that prevent
use of the device if not properly positioned in the test stand. The device can be used beyond the
test stand but requires an extra component fixed to the tube output to override the interlocks. A
trigger is applied to turn on the x-ray tube which will then feature flashing lights on its sides for
safety, indicating that the device is emitting x-ray beam.
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In addition to its electronic specifications, the device weighs about 3lbs with small dimensions.
Its lightweight and small size makes it portable and mobile. Not only that, it produces efficient
detection of elements within short duration of sampling time. This makes it ideal to be
transported to places where desired testing takes place. Patients with metal contamination do not
need to come to lab. Instead, the XRF device can be brought to them. Also, the cost of
transportation and sample processing is greatly reduced making it suitable for clinical studies in
remote areas.

This technology can analyze samples non-destructively, without causing any damage to the
material of interest. The samples for this method of analysis can be solid, powder, or even liquid.
Hence, sample preparation is also easy and does not involve elaborate process.

1.2.3 XRF for the In Vivo Quantification of Metals
XRF technology has been used extensively to quantify metals in human body based on in vivo
measurements. The primary motive for using this technology is its non-invasive ability. In one
study, portable XRF capability to quantify bone lead was compared against conventional KXRF
equipment (Nie et al., 2011). Researchers wanted to determine if portable XRF can be developed
and used for detection and quantification of bone lead non-invasively which was later affirmed
(Nie et al., 2011). Another research group also investigated the application of XRF for measuring
bone lead. Using synchrotron radiation and portable XRF device, the contrasting and overlapping
features in data output were determined (Groskopf, Bennett, Gherase, & Fleming, 2017). Besides
establishing the effectiveness of using portable LXRF for bone lead quantification, further efforts
were made to identify the optimal settings combination that will reduce the minimum detection
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limit (MDL) (Aaron James Specht, Weisskopf, & Nie, 2014). The MDL achieved by this
research group for bone lead quantification is 2.9 µg/g (ppm) with 2mm of soft tissue based on
180 seconds measurement time (Aaron James Specht et al., 2014).

Besides lead, another metal studied using XRF principle is cadmium. Three XRF systems, all
consisting of cadmium-109 (either 0.35GBq or 2.8GBq) excitation source but different detectors
(two of which are HpGe and one is lithium drifted silicon [Si(Li)]), were compared to determine
their ability to quantify bone cadmium based on MDL (Popovic, Chettle, McNeill, & PejovićMilić, 2006). Best detection system was cloverleaf design which consisted of four HpGe that
resulted in MDL of 2.1 µg/g (ppm) with 3mm of wax covering the phantoms to simulate soft
tissue (Popovic et al., 2006).

Additionally, portable XRF device was studied to determine and demonstrate its validity to
quantify bone strontium based on children population (Aaron J. Specht, Mostafaei, Lin, Xu, &
Nie, 2017). It has also been used to measure toenail manganese and mercury in vivo. The MDL
achieved for manganese and mercury are 3.65 µg/g (ppm) and 0.55 µg/g (ppm) respectively
using 1mm thick nail phantoms placed on 1cm thick lucite which mimics soft tissue based on
180 seconds measurement time (Zhang, Specht, Weisskopf, Weuve, & Nie, 2018).

1.2.4 XRF for the In Vivo Quantification of Arsenic in Skin
The XRF technology has also been used to investigate the detection and quantification of arsenic
in human skin. One of the earliest work done in this field employed a system with iodine-125 as
its fluorescing source and achieved a range of MDL from 2.6±0.5 µg/g (ppm) to 5.7±1.1 µg/g
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(ppm) (Studinski, McNeill, Chettle, & O'Meara, 2005). The same research group used a 50 W xray tube with molybdenum target with 35kV and 200µm molybdenum filter to achieve a MDL of
0.40±0.06 µg/g (ppm) (Studinski, McNeill, O'Meara, & Chettle, 2006). In this research, various
setting combinations were explored and its MDL measured. Based on these two studies alone, it
is evident that the use of x-ray tube technology instead of radioactive source contributes to great
improvement in arsenic detection limits.

Later, human samples were used to validate the effectiveness of portable XRF system in
measuring arsenic. Clippings of human finger and toe nails were extracted from subjects for
analysis (McIver et al., 2015). This study tested portable XRF device on extracted nail clippings
from a population affected by arsenic contamination, compared the results against that obtained
by ICP-MS, and determined the valid data range to identify suitable settings for portable device
(McIver et al., 2015). XRF and ICP-MS results conformed to each other better when the mass of
nail samples were greater, 20-30mg (McIver et al., 2015).

Portable XRF (4W Au anode Olympus InnovX Delta) and benchtop XRF (25W Ag anode by
XOS) systems were compared in measuring selenium and arsenic (Shehab, 2016). The MDL for
portable XRF is 0.59±0.03 µg/g (ppm) for arsenic based on 1 minute measurement time while
the MDL for the benchtop system produced 0.35±0.01 µg/g (ppm) based on 30 minutes
measurement time (Shehab, 2016). Similarly, two portable XRF devices, Olympus InnovX Delta
and InnovX Alpha, were tested against each other to measure arsenic (Desouza et al., 2017).
Both devices employed 40kVp but different tube current for each system; 37µA or 17µA for the
former and 20µA for the latter (Desouza et al., 2017). Based on 120 seconds of measurement
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time, the better MDL of 0.462±0.002 µg/g (ppm) was achieved by the Delta model (Desouza et
al., 2017).

1.3 Objectives of the Project
The aim of this research is to determine the feasibility of using portable XRF device for detecting
and measuring arsenic in human skin. As mentioned earlier, there are a few biomarkers for
arsenic such as hair, nails, and skin due to their keratin levels. In this study, skin will be the
biomarker of choice. Skin, especially under the feet close to heels, is one of the thickest site and
furthest from bone. The distance of bone from skin surface is an important consideration here to
avoid a possible interference from Pb Lα if the individual is exposed to both arsenic and lead
contamination. Not only that, the surface of skin is exposed and a specific area can be marked for
repeated or multiple readings. The same site can be used to study cumulative arsenic exposure
over a period of time. Also, there is insufficient data of arsenic accumulation in human skin
available. Hence, skin under the heels is an ideal in vivo measurement site.

The first step in this research is to perform system calibration using arsenic-doped skin
phantoms. In order to do this calibration, skin phantoms that simulate the photon interaction
properties of human skin will be produced. The composition of skin phantoms and steps for
making phantoms are determined. Then, the effect of underlying soft tissue will be studied to
understand its contribution towards arsenic signal intensity from superficial layers of skin.

Finally, the minimum detection limits for the system will be determined. These values will be
compared with other similar studies that have measured arsenic with portable XRF systems. Any
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differences in values will be discussed with plausible explanations. The long term goal is to
develop this portable XRF device to record arsenic exposure in human population based on skin
under the heels as measurement site.
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CHAPTER 2: MATERIALS AND METHODS

2.1 Portable XRF Skin Arsenic Measurement System
In this research, a customized portable XRF device was employed (Niton XL3t GOLDD+,
Thermo Fisher Scientific Inc., Billerica, MA). This device, shown in Figure 1, is compact with
optimized geometry. Throughout this research, this portable XRF device was used to collect all
fluorescence data.

Figure 1 XL3t GOLDD+ portable XRF device from Thermo Fisher Scientific

The device was fixed to a stand, provided by the manufacturer, with shielding lid as shown in
Figure 2.
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Figure 2 Device was fixed to the base of
stand with shielding lid

This shielding lid prevents any radiation leakage and contamination from external radiation
sources. Since the device is attached to the stand, the setup is simply referred to as stand mode.
An alternative way to using this device to take measurement is to simply hold it in a point-andshoot fashion directed towards the sample. This method is useful for in vivo measurements where
the geometry and angle is subject to variations. However, the device has to be stationary with
constant geometry for the purpose of data collection in this research. Hence, the device is affixed
to the bottom of the stand to direct the beam in an upward manner. The cross sectional area of
beam spot in contact with the phantom surface is approximately 1.13cm2 with a diameter of
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1.2cm. An interlock is present between the device and stand. It is a safety feature that enables the
user to handle the device safely and prevents any mishandling that could lead to unnecessary
radiation exposure. A highlight of this customized device is that it allows user to specify settings
such as tube voltage, current, and filter. Its maximum power is 50kV. In this study, the settings
were chosen to be 50kV and 40µA. Silver filter combination was used. Once the type of sample
is chosen, the camera is activated and aids to position the phantom so that it aligns with the x-ray
beam. X-ray beam is generated when the trigger is pressed; flashing lights on the sides turn on
instantaneously as an indication of x-ray beam production and for additional safety precautions.

2.2 Arsenic-doped Skin Phantoms and System Calibration
The system calibration required phantoms that replicate human skin in terms of photon
interaction properties. Total photon attenuation at 10.54 keV (As Kα) and photoelectric
absorption at 22.1 keV (Ag anode) was used as the basis for synthesizing skin phantoms. These
information for fiberglass resin, salt, human skin, and phantoms were obtained from XCOM
website and presented in Table 1 below. Using the obtained values, a fiberglass resin and salt
mixture was determined to produce skin phantoms. Since the resin matrix was fixed from the
manufacturer, the photon interaction properties based on its elemental composition cannot be
changed. In order to alter the photon interaction properties of resin, table salt was proposed as an
additional ingredient. This method has been used in another study to produce toenail phantoms
(Zhang et al., 2018). Based on the information in Table 1, the proportion of 97% resin and 3%
salt was calculated to best represent human skin. The difference in values between skin phantom
and human skin is due to the photon attenuation and photoelectric absorption contribution from
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additional elements present in human skin in trace amounts which were not included in the
calculation here.
Table 1 Elemental composition and density of resin and salt to produce skin phantoms that
mimic human skin based on total photon attenuation and photoelectric absorption properties
Substance
Major elements
Density
Total attenuation at
Photoelectric
(%)

Resin

C (60), O (35), H

(g/cm3)

10.54keV As K-alpha

absorption at 22.16keV

(cm2/g)

(cm2/g)

1.20

3.03

0.25

(5)
Salt

Na (39), Cl (61)

2.17

35.26

3.77

Skin

C (58.2), O

1.23

3.99

0.35

phantom

(33.95), H (4.85),

1.10

3.83

0.32

Na (1.17), Cl
(1.83)
Human

O (62), C (23), H

skin

(10), N (5)

A total of four attempts were made to produce skin-equivalent phantoms. The general steps
involved in this process will be presented first before describing the specific changes made in
later trials to improve the quality of phantoms.

Silicone molds were first prepared by rinsing them in deionized water to remove any impurities.
Once the molds were dry, they were labeled with permanent marker to distinguish their
respective arsenic concentrations. Then, empty 50ml polypropylene beakers were placed on the
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mass balance to record individual masses. Approximately 20ml of fiberglass resin (Bondo Corp.,
Atlanta, GA) was poured into each container. Once again, the containers with resin were
measured to determine the actual mass of resin. Based on the recorded resin masses, the mass of
salt that is required for each concentration was calculated using the proportion of 97% resin and
3% salt.

The calculated salt (Morton Salt Inc., Chicago, IL) mass was added to a small plastic plate for
each concentration. Whole salt cannot be added to resin directly because it will not dissolve.
Hence, deionized water in small volume was added incrementally to the plastic plate until salt
was completely dissolved. This salt solution was then added to resin. Since arsenic distribution in
human skin is unknown, it was assumed to be homogeneous for the purpose of making
phantoms. Thus, the mixture was placed on a hot plate and a magnetic stir bar added to help
produce homogeneous solution. Using the total mass of the resin and salt mixture, the amount of
arsenic for each concentration is determined in terms of mass. Mass was then converted into
volume which was drawn from arsenic atomic absorption standard solution with 999±4 mg/L
concentration (Sigma-Aldrich Corp., St.Louis, MO). Pipette (Biotix Inc, San Diego, CA) was
used to transfer arsenic volume into each beaker. After arsenic was transferred, drops of liquid
hardener were added and the mixture was allowed to continue stir well. So, phantom mixture
contained fiberglass resin, salt solution, arsenic solution, and liquid hardener. Finally, the
homogeneous mixture was poured into the labeled molds. All molds were left under a fume hood
for close to two weeks to harden and remove the strong odor from resin.
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The phantoms had arsenic concentrations of 0, 5, 10, 15, 20, and 25 ppm. Once the phantoms
have hardened, they were removed from their silicone molds and sealed in small and transparent
plastic bags. These little bags were vacuumed prior to sealing in order to prevent any formation
of air bubbles that could cause attenuation and introduce errors to the measured data signal. The
bags were once again labelled according to the arsenic concentrations in each phantom for easy
identification. Phantom thickness was measured using a micrometer screw gauge which yielded
measurements in inches. These data was then converted to millimeters for better comparison
with available phantom and skin thickness data.

During Trial 1, only 5-8 drops of liquid hardener were added to the phantom mixture. These
phantoms were then left under a fume hood for almost three weeks to harden. In the second trial,
silicone molds with round horizontal cross section and trapezoidal vertical cross section were
used due to availability in lab. Since these molds were taller than the phantom thickness required
for this study, the desired thickness was achieved by first calculating the volume of mold for a
height of 1mm and 2mm. Then, the mass of phantom solution was determined based on the
volume of mold and density of phantom mixture. Also, liquid hardener was increased to 10-15
drops. Round and cylindrical silicone molds with approximately 2mm of thickness were used in
Trial 3 instead of previously mentioned mold shape. Not only that, a dilute concentration of
arsenic solution was made using 999±4 mg/L arsenic atomic absorption standard solution. 10ml
of the standard solution was added to 40ml of deionized water to produce a 200ppm solution.
The arsenic standard solution was diluted to prevent excessive errors due to using pipette with
capacity in the microliter range. Also, five different spots on each phantom were measured to
assess arsenic homogeneity.
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In the final Trial 4, 12-15 drops of liquid hardener were added to phantom solution. This process
lasted approximately 40 minutes for each arsenic concentration with each new ingredient such as
salt solution, arsenic solution, and liquid hardener droplets added at 10 minutes intervals. For
each arsenic concentration, there were two phantoms, an extra to serve as backup. A total of
three spots on a single phantom were marked as X, Y, and Z. Each of the spots was measured
for 180 seconds using a stopwatch since the device does not have an installed timer which can
stop the measurement at the 3 minutes mark. Hence, each phantom took approximately 9-12
minutes including time to switch between different spots.

The effects of soft tissue underlying human skin were studied using lucite. Three different lucite
thickness of 0.51, 1.56, and 2.22mm were available for this study. These lucite slabs were
stacked on each other to get a range of thickness from 0.51mm to 13.90mm. In order to
determine if underlying soft tissue interferes with arsenic signal intensity, fluorescence
measurements were done by having the arsenic phantoms located in between x-ray beam and
lucite slabs. Two different measurements were performed using lucite. Firstly, a 25ppm arsenicdoped skin phantom was measured with the range of lucite thickness mentioned above. Next, all
phantoms were measured using two different lucite thickness of 4.44mm and 9.78mm.

2.3 Data Analysis
The fluorescence data was transferred via USB cable to a desktop computer in lab. Using
software provided by the manufacturer, the data was downloaded and exported in the form of
Excel spreadsheet. This spreadsheet was then subjected for analysis using Matlab. For spectral
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analysis, single-peak fitting was conducted. The As Kα peak was fitted with energy range of
10.2-11.03keV. Arsenic peak was fitted using Equation 1 and non-linear least squares algorithm.
The background was described as exponential.
𝑓(𝑥) = 𝐴𝑒 [−0.5(

𝑥−𝐵 2
) ]
𝐶

+ 𝐹𝑒 𝑥𝐺

(1)

In this equation, A refers to the amplitude of As Kα peak. B represents the peak position while C
is the standard deviation. F is the amplitude of background counts. X is the channel number.

The highest concentration phantom, 25ppm was fitted first to identify the position and width of
the As Kα intensity peak. Width can be determined from the value of c in the equation above.
25ppm phantom was chosen as it yielded the highest signal intensity for the available range of
arsenic-doped skin phantoms. Then, this fit was applied to measure the net count rates of the
phantoms with lower arsenic concentrations.
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CHAPTER 3: RESULTS

3.1 Spectrum of Phantom Measurements
As mentioned before, a total of four trials were made to produce valid skin phantoms by the end
of this research. Each consecutive phantom making process involved corrections to errors made
from the previous attempts. The results from all four sets of phantoms, except for the first
attempt, will be presented here because phantoms from Trial 1 did not harden regardless of
extensive time allowed and had to be eliminated.

In order to study the effects of skin thickness on arsenic signal intensity, two sets of round
phantoms were produced during the second trial. The phantom surface area was approximately
7.07cm2 with a diameter of 3cm. A sample phantom from this trial is shown in Figure 3.

Figure 3 10ppm arsenic-doped skin phantom from Trial 2
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Initially, the phantoms were intended to be at 1mm and 2mm of thickness but the final
measurements were different. Thus, these phantoms were categorized generally as either thin or
thick based on measured thickness for each given arsenic-doped skin phantom. The recorded
thickness for all the phantoms from this Trial 2 is presented in the table below. Since the x-ray
beam was aligned to the center of phantoms and fluorescence data recorded, the thickness was
measured for only one position and taken as phantom thickness as the surface was even and
uniform except for the edges. The fluorescence data for this set of phantoms are presented in the
following section for calibration lines.
Table 2 Measured thickness for arsenic-doped skin phantoms from Trial 2
Category
Arsenic (ppm)
Measured thickness (mm)
Thin

Thick

0

1.18

5

1.35

10

1.68

15

1.00

20

0.91

25

0.85

0

1.73

5

2.06

10

2.11

15

1.79

20

1.47

25

1.91
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During the third trial, a different silicone mold from the previous trials was used. The molds
were round but with greater surface area resulting in phantoms with approximately 18.1cm2 with
diameter of 4.8cm. A sample phantom from this trial is shown below.

Figure 4 5ppm arsenic-doped skin phantom from Trial 3 with numbered labels for measurement
sites
For each arsenic concentration, there were two phantoms to serve as backup except for 0ppm and
25ppm. The second phantom for 25ppm was shifted before it hardened causing smearing and
uneven surface. Since the molds had same thickness, all phantoms were approximately similar
and thickness was not measured for this set of phantoms. Meanwhile, there was visible change in
phantom opacity from initial time when phantoms were made and final removal from their
respective molds. Fluorescence data was collected from five different spots, center and four spots
at right angles to each other as seen in Figure 4, for each phantom. This was done to determine if

27
the arsenic distribution in the phantoms was homogenous. Again, this data was used to plot
calibration lines and is presented later.

Phantoms produced from Trial 4 used the same silicone molds as in Trial 3. Hence, the phantoms
have similar surface area and diameter. Some phantoms made during this attempt are shown in
Figure 5. Once again, there were some spots on phantoms where the opacity was not uniform.

Figure 5 Phantoms produced from Trial 4. The phantom on the right shows the three spots
marked as X, Y and Z for measurement of fluorescence and thickness data

The full energy spectrum from the arsenic-doped skin phantoms has a range of 0-60keV although
available data is up to 50keV.
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Figure 6 Full energy spectrum from 25ppm arsenic-doped skin phantom

In the full energy spectrum shown in Figure 6, the highest intensity peak is observed at around
20.5keV. This Compton scattering peak originates from the silver (Ag) anode tube as it
undergoes scattering after interaction with the phantoms. There are multiple characteristic energy
peaks visible in the lower energy spectrum especially close to the As Kα peak as shown in Figure
7. Between the 5keV and 13keV energy range, some elemental characteristic x-ray peaks such as
6.41keV (Fe Kα), 6.95keV (Co Kα), 7.50keV (Ni Kα), 8.66keV (Zn Kα), and 9.68keV (W Lβ1)
are present. Since these peaks were observed for both 0ppm and 25ppm phantoms, they mainly
originate from the device components. For example, the device is shielded with iron material
which contributes the Fe Kα peak at 6.41keV. The arsenic peaks, Kα and Kβ, are also present in

29
the spectrum. The As Kα is significantly observed at 10.54keV while the As Kβ produces
relatively lower signal even in the 25ppm phantom.

Figure 7 Low energy spectrum displaying multiple characteristic x-ray peaks close to arsenic
peaks based on 25ppm arsenic-doped skin phantom
3.2 Spectral Analysis
The element of interest in this study is arsenic whose characteristic x-ray peaks occur at
10.54keV (As Kα) and 11.73keV (As Kβ). Since the As Kβ produced weak signal intensity even
for the highest available arsenic-doped skin phantom, only data for As Kα was fitted for spectral
analysis. Figure 8 shows the As Kα peak fitted for the 25ppm phantom which was measured for
180 seconds.
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Figure 8 Arsenic Kα peak for 25ppm phantom fitted with Gaussian equation

The As Kα peak follows a Gaussian distribution. Commonly, Pb Lα will contribute to the energy
peak close to As Kα if it is present in the system. Pb Lα has energy of 10.55keV which has high
potential of interfering with As Kα at 10.54keV. Since phantoms with arsenic concentrations
have As peaks for certain, then it is difficult to distinguish the origin of the peak. Thus, the 0ppm
phantom was used to determine the presence of lead in the measurement system. Since the 0ppm
spectra did not exhibit any peaks in that energy region, then it was ascertained that Pb is not
present in this system. Hence, there is no contamination from Pb that overlaps and interferes with
the As Kα peak intensity.

Each phantom data was analyzed using Matlab code to determine the net count rate. The count
rates and other information about the phantoms from Trial 4 are presented in the following Table
3. For each phantom, there are three count rates corresponding to the three spots identified on the
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phantom surface. The range of phantom thickness is between 1.31mm and 2.45mm. For 0ppm
phantom, the spot thicknesses have visible deviation from the other phantoms. However, since
this is just for 0ppm phantom which does not contain arsenic, the thickness is considered to be
negligible. Based on the fitted curve, the reduced χ2 values for all phantoms are in the range of
0.60 to 1.46 with an average of 0.98±0.10, indicating good fitting of the measured fluorescence
data.

Table 3 Count rates for arsenic-doped skin phantoms from Trial 4 corresponding to their
positions and thickness

Arsenic

Net Count
Χ2 Reduced

Thickness

Thickness

(in)

(mm)

(ppm)

Position

Rates (cps)

0

X

-0.55±0.18

1.46

0.097

2.45

0

Y

-0.63±0.14

0.83

0.097

2.45

0

Z

-0.54±0.22

1.45

0.076

1.92

5

X

6.32±0.20

0.82

0.052

1.31

5

Y

7.50±0.25

1.40

0.052

1.31

5

Z

7.42±0.24

1.44

0.072

1.82

10

X

13.77±0.27

1.13

0.069

1.75

10

Y

15.24±0.28

1.13

0.069

1.75

10

Z

15.38±0.28

1.01

0.070

1.77

15

X

21.75±0.21

0.70

0.066

1.68

15

Y

23.35±0.23

0.60

0.068

1.73

15

Z

21.85±0.23

0.62

0.068

1.72
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20

X

Table 3 Continued
31.62±0.28
0.72

20

Y

33.24±0.26

0.81

0.053

1.33

20

Z

29.93±0.33

1.00

0.073

1.84

25

X

39.77±0.27

0.77

0.073

1.85

25

Y

39.77±0.34

0.92

0.052

1.321

25

Z

39.52±0.38

0.77

0.074

1.880

0.073

1.84

3.3 Calibration Lines for Bare Skin Phantoms
The calibration of portable XRF device used in this study is obtained by measuring the net
counts produced by the calibration phantoms during the measurement period. As mentioned in
the data analysis section, the fluorescence data was fitted with an energy range of 10.2-11.03keV
to include only the As K𝛼 peak. The net count rates represented as the ±2σ area from the central
position under the peak of interest was provided by Matlab. These values were multiplied with
180 seconds to obtain the net counts. Then, the calculated net counts were plotted against the
arsenic phantom concentrations. Based on the information above, the calibration lines generated
for the multiple sets of arsenic-doped skin phantoms using portable XRF device is presented in
in this section. In the following plots of calibration line, only skin phantoms were used without
any backing material. The vertical axis (y-axis) represents the net counts obtained over the
measurement period while horizontal axis (x-axis) refers to arsenic concentrations using the units
of ppm which is just arsenic (µg) per dry weight of resin (g).
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The fluorescence data from Trial 2 which was recorded for 180 seconds is plotted and its
calibration lines presented in Figure 9. Since the data is for sets of thin and thick phantoms, there
are two calibration lines for comparison. Error bars are not included due to their small range
which becomes invisible in the plot. The R2 for the thin and thick set of phantoms are 0.9707 and
0.9826 respectively. On the other hand, the slope which indicates the ratio of net counts to
arsenic concentration is higher for the thick phantoms compared to the thin phantoms. This is an
expected result. However, the intercept for the thick phantoms was lower than that for the thin
phantoms. If the phantom thickness was uniform for all arsenic concentration, then the
calibration line would be shifted a little higher and the intercept for the thick phantom set will be
improved.

y = 271.5x - 97.123
R² = 0.9826

8000
7000

Net Counts
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5000

4000

y = 175.62x + 129.58
R² = 0.9707

3000
2000
1000
0
-1000

0
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10
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15
Arsenic (ppm)

20

25

Thick Phantoms

Figure 9 Calibration lines for thin and thick phantoms from Trial 2
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Fluorescence data based on phantoms from Trial 3 were used to plot calibration lines. Since five
spots on a single phantom were measured for arsenic fluorescence signal, there are five data
points for each arsenic concentration. The multiple spot measurements were performed to assess
the homogeneity of the phantoms. Also, there were two sets of data since each arsenic-doped
phantom had an extra phantom for backup. The calibration lines from these two sets of phantoms
are presented in Figure 10 and Figure 11 below.

The phantoms from Set 1 were evidently not homogeneous as can be seen in the widespread
distribution of fluorescence data points for 10, 15, 20, 25 ppm. Data points for 15 and 20 ppm
had significant deviation from the calibration line. This strongly suggested that arsenic was not
uniformly distributed in the phantoms. Hence, the resulting calibration line was poor based on
obtained R2 = 0.9453.
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Figure 10 Calibration line using phantoms from Trial 3 for Set 1
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The phantoms from Set 2 were better than Set 1. The fluorescence data points are distributed
closer to each other especially for 10, 15, and 20 ppm as compared to the phantoms with same
concentration in Set 1. Thus, the calibration line was improved based on obtained R2 = 0.9689 as
data points were closer to each other and to the calibration line. Nevertheless, this again
suggested that arsenic is distributed in a non-homogeneous manner in each phantom.
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Figure 11 Calibration line using phantoms from Trial 3 for Set 2

In order to better compare the distribution of fluorescence data points and determine the
homogeneity of the phantoms, both calibration lines were plotted together. This is shown in
Figure 12. This was an important step towards understanding the errors in making a
homogeneous arsenic-doped skin phantom set.
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Figure 12 Comparison of both calibration lines from Trial 3
Phantoms from Trial 4 were produced based on closer attention to details and corrections to
errors made in previous attempts. But, the phantom surface was not even and therefore the
thickness was not uniform. Hence, three spots were selected based on opacity of phantoms to
ensure consistency of arsenic distribution. This resulted in three fluorescence data points for each
phantom. The fluorescence data and measured thickness was presented earlier in Table 3. Here,
the calibration line plotted based on net counts is shown in Figure 13 below. As can be seen from
the plot, the data points are very close to each other and sometimes overlap. The distance
between the data points and calibration line is also minimal resulting in an improved R 2 value.
The obtained R2 = 0.9961 is significantly better compared to previous set of phantoms.
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Figure 13 Calibration line for arsenic-doped skin phantoms from Trial 4
3.4 Calibration Lines for Skin Phantoms and Lucite Backing

Lucite was used as backing material to simulate the soft tissue layers beneath human skin. First,
a 25ppm arsenic-doped skin phantom was measured for arsenic fluorescence data with a range of
available lucite thickness. The purpose of this measurement was to determine the interaction of
backscattered photons from varying thickness of underlying soft tissue and its effect on obtained
arsenic fluorescence data. This will replicate in vivo measurement environment as different
individuals will have varying soft tissue thickness. It is expected that the net counts from arsenic
fluorescence will increase as more lucite thickness is added and saturate at a certain thickness.
The measured data for this experimental setup is presented in Figure 14. In contrary to expected
data distribution, the net counts obtained significantly drops after 10mm of lucite thickness.
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Figure 14 As Kα fluorescence net counts using 25 ppm arsenic-doped skin phantom for a range
of lucite thickness, 0.51mm to 13.9mm
Next, only two lucite thickness of 4.44mm and 9.78mm were selected. Phantoms from Trial 4
were used to measure the net counts of arsenic fluorescence data. This was done to determine the
feasibility of portable XRF device to detect As Kα signal intensity given thin and thick
deposition of underlying soft tissues. The net counts were plotted against arsenic concentrations
and calibration lines plotted in Figure 15 and 16 respectively for each lucite thickness. Error bars
are included but are not visible due to their small range. The obtained R2 for 4.44mm and
9.78mm lucite thickness are 0.9935 and 0.9949 respectively. This shows good correlation
between measured net counts and corresponding arsenic value in each phantom given the
presence of lucite backing material.
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Figure 15 Calibration line based on phantoms from Trial 4 plotted against arsenic concentrations
for 4.44mm of lucite
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Figure 16 Calibration line based on phantoms from Trial 4 plotted against arsenic concentrations
for 9.78mm of lucite
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Both calibration lines for the different lucite thickness are combined and presented in a single
plot below.

8000
9.78mm Lucite y = 306.98x - 94.536; R² = 0.9949
7000

4.44mm Lucite y = 306.55x - 214.79; R² = 0.9935

6000
Net Counts

5000
4000
3000
2000
1000
0
-1000

0

5

10

15

20

25

30

Arsenic (ppm)
4.44mm Lucite

9.78mm Lucite

Figure 17 Comparison of calibration lines obtained for measurement of arsenic fluorescence data
using phantoms from Trial 4 and lucite, 4.44mm and 9.78mm
The slope which gives the ratio of net counts to corresponding arsenic concentration shows
significantly overlapping values for the two given lucite thickness. This shows that lucite
thickness does not greatly affect arsenic signal detection for this portable XRF device.

3.5 Detection Limit of the System
The instrumental minimum detection limit (MDL) refers to the least quantity of element of
interest, arsenic in this study, which can be detected by the portable device. The detection limit is
based on background counts under peak of interest and the slope of calibration line. For this
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study, the MDL was determined using Equation 2. This equation is commonly used in
determination of MDL for XRF systems.
𝑀𝐷𝐿 =

2√𝐵𝐾𝐺0𝑝𝑝𝑚
𝑚

(2)

The BKG0ppm in the equation refers to background counts under the As Kα peak obtained from
all fluorescence data measured for 0ppm skin phantom which does not contain any amount of
arsenic. In this equation, m refers to the slope of the calibration line, generated based on linear
least-square method with y = mx+b.

In order to determine the background counts, the standard deviation (σ) for 25 ppm phantom was
first identified. This was done using the fitted curve via Matlab where the c as mentioned in
Equation 1 provides sigma value. Matlab also generates this value as width in its command
window section. Based on this sigma value, the maximum and minimum energy range was
identified by adding and subtracting 2σ from the As Kα peak central position respectively. Once
this energy range was identified, all count rates within this energy range from 0 ppm which can
be obtained from Excel spreadsheet was summed and multiplied with 180 seconds to get total
counts. Now, this sum of counts was taken as background counts and squared in Equation 2.

Using the above mentioned steps, the MDL for bare phantoms from Trial 4 without any backing
material was calculated. The width and arsenic peak position from the fitted curve for 25ppm
were 0.07 and 10.57keV respectively. Based on this information, the energy range calculated is
10.42-10.71keV. Now, the measured fluorescence data from 0ppm based on the calculated
energy range was summed to 3.19cps. This sum was multiplied with 180 seconds to get total
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background counts which as was 574.14. Finally, the MDL was determined using Equation 2
which resulted in 0.17ppm (µg/g).

Next, the same steps were used to calculate the MDL values for the in vivo simulation
environment based on phantoms with lucite backing material. The calculated values are
summarized in the table below.

Table 4 Summary of values calculated to determine the instrumental minimum detection limit for
phantoms with lucite backing
Lucite thickness (mm)
4.44
9.78
Standard deviation or width (σ)

0.08

0.07

2σ

0.15

0.15

As Kα peak position (keV)

10.57

10.56

Energy range (keV)

10.42 – 10.72

10.41 – 10.71

Total background counts

1005.33

1206.73

Slope

306.55

306.98

MDL (µg As/ g)

0.21

0.23
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CHAPTER 4: DISCUSSION AND CONCLUSION

This current study investigated the feasibility of using the XL3t GOLDD+ portable XRF device
to detect and quantify arsenic deposition in human skin. The system was validated using arsenicdoped skin phantoms to simulate human skin and lucite to mimic the underlying soft tissue layer.
Also, minimum detection limit was determined in this study after performing system calibration
and spectral analysis.
The nature of arsenic distribution in human skin besides its affinity towards keratin is unknown.
It is not clear whether arsenic follows either homogeneous or inhomogeneous pattern in human
skin. Furthermore, keratin is abundant in the superficial layers of the skin and hence constitutes
only a thin portion of human skin. Since arsenic distribution in skin is not fully understood, the
exact thickness for skin phantom is vague. The thickness of skin as measured via ultrasound in
an earlier study using XRF for measuring arsenic in skin was in the range of 1.0-2.6mm
(Studinski et al., 2005). Hence, arsenic-doped skin phantoms in the range of 1.5mm were
attempted for this study.

The major challenge in this research was to produce a set of valid skin-equivalent phantoms. As
mentioned earlier, it took four attempts to achieve an acceptable set of arsenic-doped skin
phantoms using a mixture of fiberglass resin, salt solution, arsenic standard solution, and liquid
hardener. Phantoms that were made in Trial 1 were not effectively produced. Some possible
reasons for this are the less drops of liquid hardener added to the phantom mixture and extended
time where the phantoms were left under the fume hood.
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Although specific thicknesses, 1mm and 2mm, was attempted during the second trial, it was not
feasible given the method used to achieve such values. The molds did not have exact thickness at
either 1mm or 2mm. In order to achieve these thicknesses, the mass of phantom mixture was
calculated and measured to fill the mold to the height of 1mm and 2mm. This method introduced
errors associated with measurement of volumes of mold and mass of phantom mixture especially
given the small values involved. Hence, this resulted in inconsistent phantom thickness. Not only
that, the arsenic standard solution was not diluted in this trial. Volumes of arsenic solution in the
microliter range were required to achieve the necessary arsenic concentrations in each phantom.
However, the phantoms were removed from under the fume hood earlier than was allowed for in
Trial 1 since low temperature was later determined as a factor that slows down the hardening
process.

Phantoms produced during Trial 3 resulted in a widespread distribution of fluorescence data.
This strongly suggested that the arsenic was not mixed well if not homogeneously. The time
allowed for the phantom mixture to be mixed was short which could have led to uneven
deposition of arsenic. Besides that, the phantom opacity changed throughout its hardening
duration under the fume hood. This pattern was observed in phantoms produced in Trial 4. The
possible explanation for this phenomenon is evaporation. The phantoms were left under the fume
hood where evaporation could have affected the solution before it settled uniformly. Thus, three
spots were selected for each phantom where the opacity was uniform in order to ensure
consistency. The fluorescence data measured for the spots resulted in improved conformity with
the expected distribution. Hence, the phantoms from Trial 4 were used to perform other
experimental measurements.
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In this study, lucite was used as a backing material to simulate soft tissue. As mentioned earlier,
the net counts obtained using 25ppm arsenic-doped skin phantom for varying lucite thickness
was expected to increase and then saturate. This is because the added backing layer will generate
backscattered photons that redirect into the skin phantom and produce more arsenic fluorescence
signal intensity. However, the experimental data does not conform to this pattern. Instead, the net
counts begin dropping after using approximately 10mm of lucite. The reason for this distribution
is unknown. A possible explanation for such reduction in net counts is the presence of air gap
between the lucite layers and phantom surface. This is because the lucite slabs have flat and even
surface. Furthermore, the geometry effect is less because the phantom was held in the same
position using a tape while slabs of lucite were added for multiple measurements.

The minimum detection limit (MDL) achieved in this research is compared against similar
studies in recent times. In this study, the XL3t GOLDD+ portable XRF device was set to 50kV,
40µA, and combined with silver filter that resulted in a MDL value of 0.17ppm using bare
phantoms. The MDL increased to 0.21ppm and 0.23ppm upon adding 4.44mm and 9.78mm
lucite as backing material for the phantoms. These values are lower than that achieved by recent
studies using the Olympus Innov-X Delta models. One study achieved 0.462±0.002ppm
(Desouza et al., 2017) while another study obtained 0.59±0.03ppm (Shehab, 2016). Since the
measurement times are different for these studies, the MDL values must be normalized to 3
minutes to be compared with the MDL obtained in this current research. If the aforementioned
studies were to be conducted for 180 seconds as in this current research, the MDL values will
improve by √1.5 and √3 to yield 0.38ppm and 0.34ppm respectively. Based on available skin-
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scales data among population exposed to arsenic, the arsenic concentration has been reported
with a geometric mean of 0.90ppm (Samanta, Sharma, Roychowdhury, & Chakraborti, 2004).
Hence, the portable device used in this current research is able to detect and quantify arsenic
concentration among population in arsenic contaminated areas. There are some reasons for
which the MDLs achieved in this research are lower in comparison to literature. Firstly, the tube
settings of voltage and current are higher which results in greater photon production. High tube
voltage increases energy of photons while high tube current releases more electrons from the
target material. This combined effect will produce higher intensity of photons. Next, this
research performed 180 seconds of measurement time in contrary to 120 seconds (Desouza et al.,
2017) and 60 seconds (Shehab, 2016). Longer measurement time allows for more detection of
arsenic fluorescence resulting in greater peak intensity.

However, there are more improvements that can be made in future works. A better method that
can be used in future works is to make a thick phantom and slice it to the desired thickness. This
will produce phantoms with uniform thickness across the surface. It is safe to assume that arsenic
distribution in human skin is homogenous for the purpose of making phantoms until more
information is available. Besides that, the device can be further optimized by comparing the
experimental values to simulation generated using Monte Carlo methods. This will provide more
details on the ideal tube settings for arsenic detection. Since the long-term goal of this project is
to measure arsenic exposure based on skin under heels as measurement site, an actual trial can be
performed to determine the response of the device in vivo. This will also provide information that
can be compared against skin phantoms to determine if the calibration phantoms match in vivo
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environment. Finally, dosimetry test must be conducted based on the tube settings to determine if
the device is suitable for clinical purposes.
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